Actively Recruiting

Age: 18Years +
All Genders
ID06759831

Clinical and Immunological Outcomes of Living and Deceased Donor Transplantation

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-06

1293

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to investigate the long-term outcomes of kidney transplants from different types of donors, focusing on how well the transplanted kidneys function over time. The study is observational, meaning it collects information without using additional treatments or interventions. It includes patients who have received kidney transplants and monitors their kidney function to understand the prognosis depending on donor type. The study systematically collects clinical data from kidney transplant patients starting from January 1, 2017, and will continue data collection for nine years after the study begins in November 2024. Patients receive treatment as usual based on their physician's judgment, and no extra study-specific visits or tests are required. All data is gathered during routine care without any changes to standard treatment plans. Participants are followed over a long period, with kidney transplant function assessed at 1 month, 6 months, 1 year, 5 years, and 10 years after transplantation. The study involves reviewing clinical information collected during regular treatment visits, ensuring participants do not have additional procedures solely for the study. This approach allows researchers to evaluate transplant outcomes while patients continue their usual medical care.

CONDITIONS

Brief Title

Clinical and Immunological Outcomes of Living and Deceased Donor Transplantation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age �318 years.
  • Kidney transplant recipient from any donor.
  • Acquisition of Informed Consent to study participation and data processing.
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 9 years

Participants who undergo routine care are observed and clinical information is systematically collected during their normal course of treatment after kidney transplantation.

Assessments at 1 month, 6 months, 1 year, 5 years, and 10 years after transplantation

Trial Site Locations

Total: 1 location

1

IRCCS Sant'Orsola University Hospital - Nephrology, Dialysis and Transplant Unit

Bologna, BO, Italy, 40138

Actively Recruiting

Loading map...

Research Team

G

Giorgia Comai, MD

G

Gaetano La Manna, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Multicentre, Controlled, Randomised and Single-blind, Adap...

Kidney Disease, Chronic

Actively Recruiting

1 location

Tolerance Through Mixed Chimerism (Sip-Tego) for Kidney Tran...

Kidney Failure

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here